The rapid advancement of micro- and nanomaterials is reshaping pharmaceutical science and driving innovations in targeted therapy, controlled drug delivery, and personalized medicine. This special issue provides a platform for cutting-edge research on the design, synthesis, characterization, and biomedical application of novel micro- and nanopharmaceuticals. We particularly encourage studies on stimuli-responsive and multifunctional nanocarriers capable of site-specific delivery to improve therapeutic outcomes in complex conditions such as cancer, infectious diseases, neurological disorders, and chronic inflammatory diseases. Broader topics include the integration of nanotechnology in medicine, pharmaceutical engineering, toxicological assessments, and translational research involving animal studies and clinical trials.

Submissions addressing scalable technologies and interdisciplinary approaches that bridge chemistry, biology, toxicology, and clinical medicine are especially welcome. By fostering dialogue across disciplines, this issue aims to accelerate the translation of material innovations into real-world therapeutic applications and promote the integration of nanotechnology into contemporary healthcare.